High Dose I-131 Metaiodobenzylguanidine(MIBG) for Metastatic Neuroendocrine Tumors

Clinical trial NCT00037869 · COMPLETED

Trial details

NCT number: NCT00037869
Sponsor: M.D. Anderson Cancer Center
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Neuroendocrine Tumors Metastases, Neoplasm

Start date: 2001-11-01
Primary completion: 2005-01-01
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.